[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Screening Technology Market - Global Outlook and Forecast 2021-2027

April 2021 | 109 pages | ID: C3CB6262B40CEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cancer Screening Technology in Global, including the following market information:

Global Cancer Screening Technology Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cancer Screening Technology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Screening Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Screening Technology Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cancer Screening Technology Market Segment Percentages, By Type, 2020 (%)
  • Instrument-based Inspection
  • Platform-based Inspection
China Cancer Screening Technology Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cancer Screening Technology Market Segment Percentages, By Application, 2020 (%)
  • Lung Cancer Screening
  • Breast Cancer Screening
  • Prostate Cancer Screening
  • Colorectal Cancer Screening
  • Blood Cancer Screening
  • Liver Cancer Screening
  • Pancreatic Cancer Screening
  • Skin Cancer Screening
  • Cervical Cancer Screening
  • Other
Global Cancer Screening Technology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cancer Screening Technology Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cancer Screening Technology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cancer Screening Technology Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott
  • BD
  • Siemens Healthineers
  • GE Healthcare
  • F. Hoffmann-La Roche
  • Olympus Corporation
  • FUJIFILM Corporation
  • Agilent Technologies
  • Eiken Chemical
  • Hitachi Chemical (Kyowa Medex)
  • Clinical Genomics Pty Ltd (Quest Diagnostics)
  • Sysmex
  • QIAGEN
  • R-Biopharm
  • Immunostics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Screening Technology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Screening Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER SCREENING TECHNOLOGY OVERALL MARKET SIZE

2.1 Global Cancer Screening Technology Market Size: 2021 VS 2027
2.2 Global Cancer Screening Technology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Screening Technology Players in Global Market
3.2 Top Global Cancer Screening Technology Companies Ranked by Revenue
3.3 Global Cancer Screening Technology Revenue by Companies
3.4 Top 3 and Top 5 Cancer Screening Technology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer Screening Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Screening Technology Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Screening Technology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Screening Technology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cancer Screening Technology Market Size Markets, 2021 & 2027
  4.1.2 Instrument-based Inspection
  4.1.3 Platform-based Inspection
4.2 By Type - Global Cancer Screening Technology Revenue & Forecasts
  4.2.1 By Type - Global Cancer Screening Technology Revenue, 2016-2021
  4.2.2 By Type - Global Cancer Screening Technology Revenue, 2022-2027
  4.2.3 By Type - Global Cancer Screening Technology Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Screening Technology Market Size, 2021 & 2027
  5.1.2 Lung Cancer Screening
  5.1.3 Breast Cancer Screening
  5.1.4 Prostate Cancer Screening
  5.1.5 Colorectal Cancer Screening
  5.1.6 Blood Cancer Screening
  5.1.7 Liver Cancer Screening
  5.1.8 Pancreatic Cancer Screening
  5.1.9 Skin Cancer Screening
  5.1.10 Cervical Cancer Screening
  5.1.11 Other
5.2 By Application - Global Cancer Screening Technology Revenue & Forecasts
  5.2.1 By Application - Global Cancer Screening Technology Revenue, 2016-2021
  5.2.2 By Application - Global Cancer Screening Technology Revenue, 2022-2027
  5.2.3 By Application - Global Cancer Screening Technology Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Screening Technology Market Size, 2021 & 2027
6.2 By Region - Global Cancer Screening Technology Revenue & Forecasts
  6.2.1 By Region - Global Cancer Screening Technology Revenue, 2016-2021
  6.2.2 By Region - Global Cancer Screening Technology Revenue, 2022-2027
  6.2.3 By Region - Global Cancer Screening Technology Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cancer Screening Technology Revenue, 2016-2027
  6.3.2 US Cancer Screening Technology Market Size, 2016-2027
  6.3.3 Canada Cancer Screening Technology Market Size, 2016-2027
  6.3.4 Mexico Cancer Screening Technology Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cancer Screening Technology Revenue, 2016-2027
  6.4.2 Germany Cancer Screening Technology Market Size, 2016-2027
  6.4.3 France Cancer Screening Technology Market Size, 2016-2027
  6.4.4 U.K. Cancer Screening Technology Market Size, 2016-2027
  6.4.5 Italy Cancer Screening Technology Market Size, 2016-2027
  6.4.6 Russia Cancer Screening Technology Market Size, 2016-2027
  6.4.7 Nordic Countries Cancer Screening Technology Market Size, 2016-2027
  6.4.8 Benelux Cancer Screening Technology Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cancer Screening Technology Revenue, 2016-2027
  6.5.2 China Cancer Screening Technology Market Size, 2016-2027
  6.5.3 Japan Cancer Screening Technology Market Size, 2016-2027
  6.5.4 South Korea Cancer Screening Technology Market Size, 2016-2027
  6.5.5 Southeast Asia Cancer Screening Technology Market Size, 2016-2027
  6.5.6 India Cancer Screening Technology Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cancer Screening Technology Revenue, 2016-2027
  6.6.2 Brazil Cancer Screening Technology Market Size, 2016-2027
  6.6.3 Argentina Cancer Screening Technology Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Screening Technology Revenue, 2016-2027
  6.7.2 Turkey Cancer Screening Technology Market Size, 2016-2027
  6.7.3 Israel Cancer Screening Technology Market Size, 2016-2027
  6.7.4 Saudi Arabia Cancer Screening Technology Market Size, 2016-2027
  6.7.5 UAE Cancer Screening Technology Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Cancer Screening Technology Major Product Offerings
  7.1.4 Abbott Cancer Screening Technology Revenue in Global (2016-2021)
  7.1.5 Abbott Key News
7.2 BD
  7.2.1 BD Corporate Summary
  7.2.2 BD Business Overview
  7.2.3 BD Cancer Screening Technology Major Product Offerings
  7.2.4 BD Cancer Screening Technology Revenue in Global (2016-2021)
  7.2.5 BD Key News
7.3 Siemens Healthineers
  7.3.1 Siemens Healthineers Corporate Summary
  7.3.2 Siemens Healthineers Business Overview
  7.3.3 Siemens Healthineers Cancer Screening Technology Major Product Offerings
  7.3.4 Siemens Healthineers Cancer Screening Technology Revenue in Global (2016-2021)
  7.3.5 Siemens Healthineers Key News
7.4 GE Healthcare
  7.4.1 GE Healthcare Corporate Summary
  7.4.2 GE Healthcare Business Overview
  7.4.3 GE Healthcare Cancer Screening Technology Major Product Offerings
  7.4.4 GE Healthcare Cancer Screening Technology Revenue in Global (2016-2021)
  7.4.5 GE Healthcare Key News
7.5 F. Hoffmann-La Roche
  7.5.1 F. Hoffmann-La Roche Corporate Summary
  7.5.2 F. Hoffmann-La Roche Business Overview
  7.5.3 F. Hoffmann-La Roche Cancer Screening Technology Major Product Offerings
  7.5.4 F. Hoffmann-La Roche Cancer Screening Technology Revenue in Global (2016-2021)
  7.5.5 F. Hoffmann-La Roche Key News
7.6 Olympus Corporation
  7.6.1 Olympus Corporation Corporate Summary
  7.6.2 Olympus Corporation Business Overview
  7.6.3 Olympus Corporation Cancer Screening Technology Major Product Offerings
  7.6.4 Olympus Corporation Cancer Screening Technology Revenue in Global (2016-2021)
  7.6.5 Olympus Corporation Key News
7.7 FUJIFILM Corporation
  7.7.1 FUJIFILM Corporation Corporate Summary
  7.7.2 FUJIFILM Corporation Business Overview
  7.7.3 FUJIFILM Corporation Cancer Screening Technology Major Product Offerings
  7.4.4 FUJIFILM Corporation Cancer Screening Technology Revenue in Global (2016-2021)
  7.7.5 FUJIFILM Corporation Key News
7.8 Agilent Technologies
  7.8.1 Agilent Technologies Corporate Summary
  7.8.2 Agilent Technologies Business Overview
  7.8.3 Agilent Technologies Cancer Screening Technology Major Product Offerings
  7.8.4 Agilent Technologies Cancer Screening Technology Revenue in Global (2016-2021)
  7.8.5 Agilent Technologies Key News
7.9 Eiken Chemical
  7.9.1 Eiken Chemical Corporate Summary
  7.9.2 Eiken Chemical Business Overview
  7.9.3 Eiken Chemical Cancer Screening Technology Major Product Offerings
  7.9.4 Eiken Chemical Cancer Screening Technology Revenue in Global (2016-2021)
  7.9.5 Eiken Chemical Key News
7.10 Hitachi Chemical (Kyowa Medex)
  7.10.1 Hitachi Chemical (Kyowa Medex) Corporate Summary
  7.10.2 Hitachi Chemical (Kyowa Medex) Business Overview
  7.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Major Product Offerings
  7.10.4 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Revenue in Global (2016-2021)
  7.10.5 Hitachi Chemical (Kyowa Medex) Key News
7.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
  7.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Summary
  7.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
  7.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Major Product Offerings
  7.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Revenue in Global (2016-2021)
  7.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Key News
7.12 Sysmex
  7.12.1 Sysmex Corporate Summary
  7.12.2 Sysmex Business Overview
  7.12.3 Sysmex Cancer Screening Technology Major Product Offerings
  7.12.4 Sysmex Cancer Screening Technology Revenue in Global (2016-2021)
  7.12.5 Sysmex Key News
7.13 QIAGEN
  7.13.1 QIAGEN Corporate Summary
  7.13.2 QIAGEN Business Overview
  7.13.3 QIAGEN Cancer Screening Technology Major Product Offerings
  7.13.4 QIAGEN Cancer Screening Technology Revenue in Global (2016-2021)
  7.13.5 QIAGEN Key News
7.14 R-Biopharm
  7.14.1 R-Biopharm Corporate Summary
  7.14.2 R-Biopharm Business Overview
  7.14.3 R-Biopharm Cancer Screening Technology Major Product Offerings
  7.14.4 R-Biopharm Cancer Screening Technology Revenue in Global (2016-2021)
  7.14.5 R-Biopharm Key News
7.15 Immunostics
  7.15.1 Immunostics Corporate Summary
  7.15.2 Immunostics Business Overview
  7.15.3 Immunostics Cancer Screening Technology Major Product Offerings
  7.15.4 Immunostics Cancer Screening Technology Revenue in Global (2016-2021)
  7.15.5 Immunostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Cancer Screening Technology Market Opportunities & Trends in Global Market
Table 2. Cancer Screening Technology Market Drivers in Global Market
Table 3. Cancer Screening Technology Market Restraints in Global Market
Table 4. Key Players of Cancer Screening Technology in Global Market
Table 5. Top Cancer Screening Technology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer Screening Technology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer Screening Technology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer Screening Technology Product Type
Table 9. List of Global Tier 1 Cancer Screening Technology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Screening Technology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cancer Screening Technology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancer Screening Technology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancer Screening Technology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cancer Screening Technology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancer Screening Technology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancer Screening Technology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cancer Screening Technology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancer Screening Technology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancer Screening Technology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancer Screening Technology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancer Screening Technology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancer Screening Technology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancer Screening Technology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancer Screening Technology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancer Screening Technology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancer Screening Technology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancer Screening Technology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancer Screening Technology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancer Screening Technology Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Corporate Summary
Table 31. Abbott Cancer Screening Technology Product Offerings
Table 32. Abbott Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 33. BD Corporate Summary
Table 34. BD Cancer Screening Technology Product Offerings
Table 35. BD Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 36. Siemens Healthineers Corporate Summary
Table 37. Siemens Healthineers Cancer Screening Technology Product Offerings
Table 38. Siemens Healthineers Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 39. GE Healthcare Corporate Summary
Table 40. GE Healthcare Cancer Screening Technology Product Offerings
Table 41. GE Healthcare Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 42. F. Hoffmann-La Roche Corporate Summary
Table 43. F. Hoffmann-La Roche Cancer Screening Technology Product Offerings
Table 44. F. Hoffmann-La Roche Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 45. Olympus Corporation Corporate Summary
Table 46. Olympus Corporation Cancer Screening Technology Product Offerings
Table 47. Olympus Corporation Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 48. FUJIFILM Corporation Corporate Summary
Table 49. FUJIFILM Corporation Cancer Screening Technology Product Offerings
Table 50. FUJIFILM Corporation Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 51. Agilent Technologies Corporate Summary
Table 52. Agilent Technologies Cancer Screening Technology Product Offerings
Table 53. Agilent Technologies Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 54. Eiken Chemical Corporate Summary
Table 55. Eiken Chemical Cancer Screening Technology Product Offerings
Table 56. Eiken Chemical Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 57. Hitachi Chemical (Kyowa Medex) Corporate Summary
Table 58. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Product Offerings
Table 59. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 60. Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Summary
Table 61. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Product Offerings
Table 62. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 63. Sysmex Corporate Summary
Table 64. Sysmex Cancer Screening Technology Product Offerings
Table 65. Sysmex Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 66. QIAGEN Corporate Summary
Table 67. QIAGEN Cancer Screening Technology Product Offerings
Table 68. QIAGEN Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 69. R-Biopharm Corporate Summary
Table 70. R-Biopharm Cancer Screening Technology Product Offerings
Table 71. R-Biopharm Cancer Screening Technology Revenue (US$, Mn), (2016-2021)
Table 72. Immunostics Corporate Summary
Table 73. Immunostics Cancer Screening Technology Product Offerings
Table 74. Immunostics Cancer Screening Technology Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Cancer Screening Technology Segment by Type
Figure 2. Cancer Screening Technology Segment by Application
Figure 3. Global Cancer Screening Technology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Screening Technology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancer Screening Technology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Screening Technology Revenue in 2020
Figure 8. By Type - Global Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 12. US Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 16. Germany Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 24. China Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 30. Brazil Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancer Screening Technology Revenue Market Share, 2016-2027
Figure 33. Turkey Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancer Screening Technology Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BD Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Siemens Healthineers Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GE Healthcare Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. F. Hoffmann-La Roche Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Olympus Corporation Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. FUJIFILM Corporation Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Agilent Technologies Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eiken Chemical Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Sysmex Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. QIAGEN Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. R-Biopharm Cancer Screening Technology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications